No connection

Search Results

CTRE

NEUTRAL
$37.96 Live
CareTrust REIT, Inc. · NYSE
Target $43.67 (+15.0%)
$27.27 52W Range $41.72

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 26, 2026
Market cap
$8.47B
P/E
24.18
ROE
9.2%
Profit margin
67.3%
Debt/Equity
0.72
Dividend yield
4.11%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
CareTrust REIT (CTRE) presents a dichotomy between strong balance sheet health and fundamental overvaluation. While the Piotroski F-Score of 4/9 indicates stable financial health and the Debt/Equity ratio (0.72) is significantly superior to the sector average (2.76), the stock trades at a substantial premium to its Graham Number ($25.3) and Intrinsic Value ($22.77). Recent performance is marred by a streak of four consecutive earnings misses with an average surprise of -11.89%, offsetting the bullish analyst consensus. The outlook remains neutral as the market price reflects growth expectations that are not currently supported by recent earnings delivery.

Key Strengths

Exceptional leverage profile with Debt/Equity (0.72) far below sector average (2.76)
Strong liquidity position evidenced by a Current Ratio of 2.45
High profitability margins (Profit Margin 67.28%)
Strong long-term price appreciation (5Y Change +97.7%)
Strong analyst consensus with a 'strong_buy' rating and target price of $43.67

Key Risks

Significant valuation gap between current price ($37.96) and Graham Number ($25.3)
Poor recent earnings track record (0/4 beats in the last 4 quarters)
High dividend payout ratio (85.35%) limiting capital reinvestment
Bearish technical trend (0/100 score)
Modest year-over-year revenue growth (3.20%)
AI Fair Value Estimate
Based on comprehensive analysis
$27.5
-27.6% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
56
Moderate
Value
30
Future
45
Past
70
Health
75
Dividend
60
AI Verdict
Fairly Valued to Overvalued
Key drivers: Strong balance sheet, Earnings misses, Valuation premium
Confidence
90%
Value
30/100

Ref P/E, Graham Number $25.3, Intrinsic Value $22.77

Positives
  • P/E (24.18) is lower than sector average (40.95)
Watchpoints
  • Price is ~50% above Graham Number
  • Price is ~66% above Intrinsic Value
Future
45/100

Ref Growth rates and Earnings track record

Positives
  • High analyst target price ($43.67)
  • Strong Q/Q revenue growth (72.79%)
Watchpoints
  • Low YoY earnings growth (5.00%)
  • Consistent negative earnings surprises
Past
70/100

Ref Historical price performance

Positives
  • Strong 1Y (+40.4%) and 3Y (+128.4%) returns
Watchpoints
  • Recent quarterly earnings decline relative to estimates
Health
75/100

Ref Piotroski F-Score, Debt/Equity, Current Ratio

Positives
  • Low Debt/Equity ratio
  • High Current and Quick ratios
Watchpoints
  • Piotroski F-Score is only 4/9 (Stable, not Strong)
Dividend
60/100

Ref Yield, Payout

Positives
  • Consistent yield of 4.11%
Watchpoints
  • High payout ratio (85.35%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$37.96
Analyst Target
$43.67
Upside/Downside
+15.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CTRE and closest competitors.

Updated 2026-04-24
CTR
CareTrust REIT, Inc.
Primary
5Y
+97.7%
3Y
+128.4%
1Y
+40.4%
6M
+10.1%
1M
+2.1%
1W
-3.9%
LIN
Lineage, Inc.
Peer
5Y
-53.9%
3Y
-53.9%
1Y
-30.4%
6M
-10.3%
1M
-10.9%
1W
+4.2%
ADC
Agree Realty Corporation
Peer
5Y
+38.9%
3Y
+12.4%
1Y
+5.9%
6M
+0.8%
1M
+0.6%
1W
-0.9%
AHR
American Healthcare REIT, Inc.
Peer
5Y
+278.7%
3Y
+278.7%
1Y
+65.4%
6M
+25.2%
1M
-4.0%
1W
-3.7%
AGN
AGNC Investment Corp.
Peer
5Y
+55.3%
3Y
+40.2%
1Y
+7.3%
6M
+3.6%
1M
-0.6%
1W
+0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
24.18
Forward P/E
22.3
PEG Ratio
N/A
P/B Ratio
2.1
P/S Ratio
17.79
EV/Revenue
19.14
EV/EBITDA
22.36
Market Cap
$8.47B

Profitability

Profit margins and return metrics

Profit Margin 67.28%
Operating Margin 57.79%
Gross Margin 97.99%
ROE 9.17%
ROA 4.68%

Growth

Revenue and earnings growth rates

Revenue Growth +3.2%
Earnings Growth +5.0%
Q/Q Revenue Growth +72.79%
Q/Q Earnings Growth +6.0%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.72
Moderate
Current Ratio
2.45
Strong
Quick Ratio
1.54
Excellent
Cash/Share
$0.14

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.1B
Gross Margin
99.3%
Op. Margin
58.7%
Net Margin
103.5%
Total Assets
$5.1B
Liabilities
$1.1B
Equity
$4.0B
Debt/Equity
0.27x
Operating CF
$0.1B
CapEx
$-0.0B
Free Cash Flow
$0.1B
FCF Yield
96%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-07
$N/A
2026-02-12
$0.36
-6.8% surprise
2025-11-05
$0.33
-13.2% surprise
2025-08-06
$0.33
-15.7% surprise

Real Estate Sector Comparison

Comparing CTRE against 140 companies in the Real Estate sector (5 bullish, 25 neutral, 110 bearish)
P/E Ratio
24.18
This Stock
vs
46.21
Sector Avg
-47.7% (Discount)
Return on Equity (ROE)
9.17%
This Stock
vs
-40.46%
Sector Avg
-122.7% (Below Avg)
Profit Margin
67.28%
This Stock
vs
10.6%
Sector Avg
+534.5% (Superior)
Debt to Equity
0.72
This Stock
vs
2.7
Sector Avg
-73.4% (Less Debt)
Revenue Growth
3.2%
This Stock
vs
19964.14%
Sector Avg
-100.0% (Slower)
Current Ratio
2.45
This Stock
vs
8.88
Sector Avg
-72.4% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

SEDGWICK DAVID M
Chief Executive Officer
Stock Award
2026-01-30
99,240 shares
CALLISTER JAMES
Chief Investment Officer
Stock Award
2026-01-30
58,379 shares
BEALE LAUREN
Officer
Stock Award
2026-01-02
11,133 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-03-13

CTRE filed a definitive proxy statement on March 13, 2026, providing shareholders with necessary information to vote on corporate matters at the upcoming annual meeting.

8-K
8-K
2026-03-02

CareTrust REIT, Inc. likely announced its year-end financial results or a dividend declaration in this 8-K filing.

8-K
FORM 8-K
2026-02-18

CareTrust REIT, Inc. filed a Form 8-K on February 18, 2026, likely to announce its quarterly or annual financial results.

8-K
8-K
2026-02-12

CareTrust REIT, Inc. filed an 8-K on February 12, 2026, likely to announce its fourth-quarter and full-year financial results.

10-K
10-K
2026-02-12

CTRE filed its annual 10-K on February 12, 2026, providing comprehensive disclosures regarding its business operations, risk factors, and financial condition. While specific financial metrics were not provided in the excerpts, the filing includes detailed analysis within the MD&A and Risk Factors sections.

8-K
8-K
2025-12-17
8-K
8-K
2025-11-05

CareTrust REIT, Inc. likely reported its third-quarter financial results.

10-Q
10-Q
2025-11-05

CTRE filed its quarterly 10-Q report on November 5, 2025. The filing includes a section dedicated to Risk Factors under Item 1A, although specific financial highlights were not provided in the available excerpt.

8-K
8-K
2025-10-27

CareTrust REIT, Inc. filed an 8-K on October 27, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-09-23
8-K
8-K
2025-08-14
10-Q
10-Q
2025-08-06
8-K
8-K
2025-08-06
8-K
8-K
2025-06-02
8-K
8-K
2025-05-29
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
12 analysts
Mizuho
2026-04-02
init
Outperform
Wells Fargo
2026-03-26
Maintains
Overweight Overweight
RBC Capital
2026-02-24
Maintains
Outperform Outperform
UBS
2026-02-18
Maintains
Buy Buy
Cantor Fitzgerald
2026-02-17
Maintains
Neutral Neutral
Citizens
2026-01-22
init
Market Outperform
BMO Capital
2026-01-09
up
Market Perform Outperform
UBS
2026-01-08
Maintains
Buy Buy
Jefferies
2025-12-16
Maintains
Buy Buy
Keybanc
2025-12-04
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning CTRE from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile